A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin β1 expression

Hypertension Research

Volumn 26, Issue 9, 2003, Pages 737-742

  Jia, Nan ^a   Okamoto, Hiroshi ^a   Shimizu, Toshihiro ^a   Chiba, Satoru ^a   Matsui, Yutaka ^a   Sugawara, Takeshi ^a   Akino, Masatoshi ^a   Kitabatake, Akira ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Angiotensin II type 1 receptor; Integrin; Stroke prone spontaneously hypertensive rats

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; BETA1 INTEGRIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MESSENGER RNA; OLMESARTAN; TEMOCAPRIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG EFFICACY; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT STRAIN; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIGENS, CD29; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CARDIOMEGALY; DOWN-REGULATION; DRUG THERAPY, COMBINATION; IMIDAZOLES; MALE; MYOCYTES, CARDIAC; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER; TETRAZOLES; THIAZEPINES;

EID: 0141927452     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.26.737     Document Type: Article

References (30)

1. Weber KT, Anversa P, Armstrong PW, et al: Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol 1992; 20: 3-16.
2. Cooper G 4th: Basic determinants of myocardial hypertrophy: a review of molecular mechanisms. Annu Rev Med 1997; 48: 13-23.
3. Onodera T, Okazaki F, Miyazaki H, et al: Perindopril reverses myocyte remodeling in the hypertensive heart. Hypertens Res 2002; 25: 85-90.
4. Mazzolai L, Pedrazzini T, Nicoud F, Gabbiani G, Brunner HR, Nussberger J: Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice. Hypertension 2000; 35: 985-991.
5. Sadoshima J, Xu Y, Slayter HS, Izumo S: Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993; 75: 38-46.
6. Juliano RL, Haskill S: Signal transduction from the extracellular matrix. J Cell Biol 1993; 120: 577-585.
7. Clark EA, Brugg JS: Integrins and signal transduction pathways: the road taken. Science 1995; 268: 233-239.
8. Christian F, Krieglstein D, Neil G: Adhesion molecules and their role in vascular disease. Am J Hypertens 2001; 14: 44S-54S.
9. Ross RS, Pham C, Shai SY, et al: β1 integrins participate in the hypertrophic response of rat ventricular myocytes. Circ Res 1998; 82: 1160-1172.
10. Pham CG, Harpf AE, Keller RS, et al: Striated muscle-specific β1D-integrin and FAK are involved in cardiac myocytes hypertrophic response pathway. Am J Physiol Heart Circ Physiol 2000; 279: H2916-H2926.
11. Shai SY, Harpf AE, Babbitt CJ, et al: Cardiac myocyte-specific excision of the β1 integrin gene results in myocardial fibrosis and cardiac failure. Circ Res 2002; 90: 458-464.
12. Bouzegrhane F, Thibault G: Is angiotensin II a proliferative factor of cardiac fibroblasts? Cardiovasc Res 2002; 53: 304-312.
13. Burgess ML, Carver WE, Terracio L, Wilson SP, Wilson MA, Borg TK: Integrin-mediated collagen gel contraction by cardiac fibroblasts: effects of angiotensin II. Circ Res 1994; 74: 291-298.
14. Graf K, Neuss M, Stawowy P, Hsueh WA, Fleck E, Law RE: Angiotensin II and αvβ3 integrin expression in rat neonatal cardiac fibroblasts. Hypertension 2000; 35: 978-984.
15. Kawano H, Cody RJ, Graf K, et al: Angiotensin II enhances integrin and α-actinin expression in adult rat cardiac fibroblasts. Hypertension 2000; 35: 273-279.
16. Babbitt CJ, Pham CG, Shai SY, Ross RS: Integrin signaling in pressure-overload hypertrophy. Circulation 1999; 100 (Suppl I): I-560 (Abstract).
17. Porkn JC, Hogg N: Integrins take partners: cross-talk between integrins and other membrane receptors. Trends Cell Biol 1998; 8: 390-396.
18. Sakai S, Miyauchi T, Yamaguchi I: Long-term endothelin receptor antagonist administration improves alterations in expression of various cardiac genes in failing myocardium of rats with heart failure. Circulation 2000; 101: 2849-2853.
19. Barsotti A, Di Napoli P, Taccardi AA, et al: MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: evidence of an e-NOS mRNA overexpression after global ischemia. Atherosclerosis 2001; 155: 53-59.
20. Sasamura H, Shimizu-Hirota R, Nakaya H, Saruta T: Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats. Hypertens Res 2001; 24: 165-172.
21. Makino N, Sugano M, Otsuka S, Hata T: Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats. Hypertension 1997; 30: 796-802.
22. Otsuka S, Sugano M, Makino N, Sawada S, Hata T, Niho Y: Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Hypertension 1998; 32: 467-472.
23. Sugimoto K, Fujimura A: Role of bradykinin in the reduction of left ventricular hypertrophy induced by angiotensin-converting enzyme inhibitors in spontaneously hypertensive rats. Jpn J Pharmacol 1998; 76: 431-434.
24. Timmermans PB: Angiotensin II receptor antagonists: an emerging new class of cardiovascular therapeutics. Hypertens Res 1999; 22: 147-153.
25. Hu K, Gaudron P, Anders HJ, et al: Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blocked in rats with myocardial infarction: role of bradykinin. Cardovasc Res 1998; 39: 401-412.
26. Sano M, Fukuda K, Kodama H, et al: Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem 2000; 275: 29717-29723.
27. Fukuzawa J, Booz GW, Hunt RA, et al: Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3. Hypertension 2000; 35: 1191-1196.
28. Aoki H, Izumo S, Sadoshima J: Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation. Circ Res 1998; 82: 666-676.
29. Hines WA, Thorburn A: Ras and Rho are required for Gαq-induced hypertrophic gene expression in neonatal rat cardiac myocytes. J Mol Cell Cordiol 1998; 30: 485-494.
30. Thomas K, Borg EC, Goldsmith RP, Wayne C, Louis T, Allen MS: Specialization at the Z line of cardiac myocytes. Cardovasc Res 2000; 46: 277-285.